Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Kangzhi Pharmaceutical is a subsidiary of Kangzhi Pharmaceutical, a leading Chinese pharmaceutical company specializing in pediatric healthcare. The company focuses on the research, development, and manufacturing of a wide range of pediatric medicines, including antipyretics, analgesics, and treatments for respiratory and digestive ailments. Operating out of its production base in Hebei, the company adheres to strict GMP standards to ensure the safety and efficacy of its products for children. Its portfolio includes well-known brands and generic formulations designed to meet the specific dosage and safety requirements of the pediatric population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河北康芝.